US 7,951,400

Application 11/137,068 · Granted May 31, 2011

Coated tablet formulation and method

Estimated expiration

November 30, 2028

2y 10d remaining

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
Earliest effective filing
May 25, 2005
+ 20 years
May 25, 2025
PTA +1285d
Nov 30, 2028
No TD
—
Final
Nov 30, 2028

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.

Calculation details

Base term

Filing date
May 25, 2005
Earliest effective filing
May 25, 2005
Issue date
May 31, 2011
PTA
+1285 days
Base expiry (before PTA)
May 25, 2025

May 25, 2005 + 20 years = May 25, 2025 + 1285 PTA days = November 30, 2028

  • PRO60/575,319 — Provisional — not used for base term

Terminal disclaimers

No TD0 approved, 0 filed

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 11/137,068 · US 7,951,400

PatentReply compiles the prosecution history behind US 7,951,400: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US7951400

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.